Astellas Pharma.
company
- Reports this week
- 1
- Active events
- 1
- Connections
- 54
What's happening
Earlier this month
One to three months ago
-
Manufacturers committed to a $19.6B US manufacturing investment and contributing APIs to national reserves.Some support2 reports
-
Astellas Pharma reported its Q1 financial results and future fiscal guidance on August 5, 2026.Some support1 report
-
Astellas Pharma held an award ceremony in India on July 28, 2026.Some support2 reports
-
Astellas Pharma operates a capability center in India. KPMG director serves on Indian awards jury. Business Finland is a Finnish government organization.Well supported10 reports
Gone quiet
No new reports in 90+ days-
A company based in Tokyo, Astellas Pharma, is trading as an ADR in the US market and receives analyst ratings from Jefferies Financial Group.Some support7 reports
-
Astellas Pharma and Alpha Cognition Inc. were noted for their industry classification and stock performance in the medical sector.Speculative1 report
-
Commercial deals were signed for the Padcev-Keytruda combo regimen, challenging Opdivo market share, with NHS adoption pending FDA approval.Some support1 report
-
AbbVie, Astellas Pharma, and AstraZeneca announced partnerships for the Linzess drug's sales and development in various markets.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Astellas Pharma this week
News at the entities that move Astellas Pharma most-
Donald Trump OperationalTrump, Hegseth, and Bessent discuss threats and escalation against Iranian targets in the Strait of Hormuz.Moves Astellas Pharma
-
Jefferies Financial Group Mentioned togetherJefferies Financial Group initiated coverage on Moody's shares, and Morgan Stanley subsequently raised its price target for the company.Moves Astellas Pharma
-
Amgen OperationalMSKCC director Rudin presented trial data involving Amgen on October 25, 2026.Moves Astellas Pharma
-
Teva Pharmaceutical Industries Ltd. OperationalBrian transitioned from a senior leadership role at Teva Pharmaceuticals to join Lupin Limited, where Vinita Gupta is CEO.Moves Astellas Pharma
-
Novo Nordisk OperationalOmnicom Group secured new mandates and account extensions from CVS Health, L'Oréal, Mercedes-Benz, and Novo Nordisk.Moves Astellas Pharma
-
Tokyo Stock Exchange Shared contextSumitomo Chemical was listed on the Tokyo Stock Exchange in January 2025.Moves Astellas Pharma
Connections
The 14 strongest of 54, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Donald Trump Operational
Trump's administration has been actively involved in negotiations and proposals regarding drug pricing that directly involve Astellas Pharma.
-
VIR Biotechnology Operational
Astellas Pharma and VIR Biotechnology are collaborating on the joint development of a PSMA-targeted T-cell engager.
-
Alcon Operational
Both companies are actively engaged in competitive market practices, specifically participating in Most Favored Nation (MFN) drug pricing deals.
-
Amgen Operational
Amgen and Astellas Pharma engage in strategic collaborations.
-
Teva Pharmaceutical Industries Ltd. Operational
The companies are active competitors, evidenced by their shared involvement in drug pricing agreements.
-
BridgeBio Operational
Both companies participate in the national reserve system by contributing Active Pharmaceutical Ingredients (APIs).
-
MarketBeat Mentioned together
MarketBeat provides market data and analyst ratings that Astellas Pharma utilizes for consensus ratings.
-
Kyowa Kirin Operational
Both companies are active participants in the same market pricing program and US manufacturing investment initiatives.
Show all 14 connections
-
Novo Nordisk Operational
Astellas Pharma and Novo Nordisk are direct competitors operating within the large-cap healthcare sector.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provides analyst ratings and price targets for Astellas Pharma, influencing market perception.
-
Tokyo Stock Exchange Shared context
Astellas Pharma operates within the context of the Tokyo Stock Exchange, reporting financial results there.
-
India Shared context
Astellas Pharma operates a facility and capability center within the geographical context of India.
-
Tokyo Shared context
Astellas Pharma is headquartered in Tokyo.
-
Incepta Pharmaceuticals Mentioned together
The evidence does not describe any relationship between Incepta Pharmaceuticals and Astellas Pharma.
History
Events by the month they beganOctober 2026
3 events- Novo Nordisk and Astellas Pharma are noted as large-cap healthcare companies, with Novo Nordisk reporting higher revenue and earnings.
- Astellas Pharma, a Japan-based pharmaceutical company, was noted.
- Astellas Pharma and VIR Biotechnology announced a collaboration to develop a PSMA-targeted T-cell engager.
August 2026
2 eventsJuly 2026
3 events- Astellas Pharma held an award ceremony in India on July 28, 2026.
- Astellas Pharma operates a capability center in India. KPMG director serves on Indian awards jury. Business Finland is a Finnish government organization.
- A company based in Tokyo, Astellas Pharma, is trading as an ADR in the US market and receives analyst ratings from Jefferies Financial Group.
Show 1 earlier month
June 2026
3 events- Astellas Pharma and Alpha Cognition Inc. were noted for their industry classification and stock performance in the medical sector.
- Commercial deals were signed for the Padcev-Keytruda combo regimen, challenging Opdivo market share, with NHS adoption pending FDA approval.
- AbbVie, Astellas Pharma, and AstraZeneca announced partnerships for the Linzess drug's sales and development in various markets.